IRIS Institutional Research Information System - OPENBS Open Archive UniBS

CATTINA, FEDERICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.148
AS - Asia 1.048
EU - Europa 981
SA - Sud America 136
Continente sconosciuto - Info sul continente non disponibili 68
AF - Africa 19
OC - Oceania 4
Totale 4.404
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.088
SG - Singapore 445
CN - Cina 303
DE - Germania 171
IT - Italia 153
PL - Polonia 145
UA - Ucraina 138
BR - Brasile 111
VN - Vietnam 80
FI - Finlandia 76
HK - Hong Kong 64
FR - Francia 58
RU - Federazione Russa 57
GB - Regno Unito 50
IN - India 36
SE - Svezia 35
TR - Turchia 35
CA - Canada 33
IE - Irlanda 30
BD - Bangladesh 27
MX - Messico 16
CZ - Repubblica Ceca 15
JP - Giappone 13
BE - Belgio 12
ES - Italia 12
IQ - Iraq 12
NL - Olanda 10
AR - Argentina 8
ZA - Sudafrica 6
JO - Giordania 5
UZ - Uzbekistan 5
AT - Austria 4
CO - Colombia 4
ET - Etiopia 4
PH - Filippine 4
VE - Venezuela 4
AU - Australia 3
AZ - Azerbaigian 3
EC - Ecuador 3
LT - Lituania 3
PT - Portogallo 3
AE - Emirati Arabi Uniti 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GR - Grecia 2
ID - Indonesia 2
IL - Israele 2
JM - Giamaica 2
KE - Kenya 2
LV - Lettonia 2
PY - Paraguay 2
TH - Thailandia 2
TN - Tunisia 2
AO - Angola 1
BG - Bulgaria 1
BO - Bolivia 1
CL - Cile 1
EG - Egitto 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
KR - Corea 1
KY - Cayman, isole 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MA - Marocco 1
MN - Mongolia 1
MT - Malta 1
MY - Malesia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
UY - Uruguay 1
Totale 4.336
Salva come PNG Salva come JPEG
Città #
Singapore 248
Ashburn 217
Fairfield 166
San Jose 145
Warsaw 144
Chandler 115
New York 102
Jacksonville 95
Houston 93
Ann Arbor 92
Beijing 89
Woodbridge 88
Seattle 81
Wilmington 71
Cambridge 67
Hong Kong 64
Princeton 58
The Dalles 52
Helsinki 50
Dallas 44
Los Angeles 43
Munich 42
Des Moines 39
Brescia 31
Dublin 30
Shanghai 27
Lauterbourg 26
Hanoi 23
Istanbul 23
Turku 22
Chicago 19
Boardman 17
Ho Chi Minh City 17
Rome 17
San Francisco 15
São Paulo 15
Buffalo 14
Montreal 14
Moscow 14
Orem 14
Brussels 12
Denver 12
Santa Clara 12
Tokyo 12
Brno 11
Jinan 11
Brooklyn 10
Nanjing 10
Pune 10
Toronto 10
Council Bluffs 9
Dearborn 9
Tianjin 9
Charlotte 8
Milan 8
Redondo Beach 8
Boston 7
Da Nang 7
Guangzhou 7
Mexico City 7
Nanchang 7
San Diego 7
Amsterdam 6
Atlanta 6
Chennai 6
Falkenstein 6
London 6
Manchester 6
Amman 5
Bosio 5
Johannesburg 5
Paris 5
Querétaro 5
Shenyang 5
Stockholm 5
Augusta 4
Columbus 4
Frankfurt am Main 4
Haikou 4
Hangzhou 4
Hebei 4
Kocaeli 4
Mumbai 4
New Delhi 4
Nürnberg 4
Phoenix 4
Tashkent 4
Addis Ababa 3
Alzano Lombardo 3
Baghdad 3
Baku 3
Basingstoke 3
Bergamo 3
Bologna 3
Changsha 3
Curitiba 3
Jiaxing 3
Kyiv 3
Melbourne 3
Milwaukee 3
Totale 2.904
Salva come PNG Salva come JPEG
Nome #
BACTERIAL BLOOD STREAM INFECTIONS NEGATIVELY IMPACT ON OUTCOME OF PATIENTS TREATED WITH ALLOGENEIC STEM CELL TRANSPLANTATION: 6 YEARS SINGLE-CENTRE EXPERIENCE 295
A specific Toll-like receptor profile on T lymphocytes and values of monocytes correlate with bacterial, fungal, and cytomegalovirus infections in the early period of allogeneic stem cell transplantation 212
Feasibility of tumor‑derived exosome enrichment in the onco‑hematology leukemic model of chronic myeloid leukemia 210
Comparative study on ATG-thymoglobulin versus ATG-fresenius for the graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation from matched unrelated donor: a single-centre experience over the contemporary years 199
Targeting HRASV12G Expression to the Zebrafish Early Hemogenic Progenitors Induces a Myeloproliferative Disorder by Repressing the Notch Pathway. 188
EXPRESSION OF TOLL-LIKE RECEPTORS ON PERIPHERAL BLOOD CELLS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: ONGOING RESULTS OF A PROSPECTIVE STUDY. 187
Comparative Somatic Mutational Profiling of CD34+ Hematopoietic Precursors (HSC) and Circulating Endothelial Cells (CEC) in Patients with Primary Myelofibrosis (PMF) 187
TARGETING HRASV12G EXPRESSION TO THE ZEBRAFISH EARLY HEMOGENIC PROGENITORS INDUCES A MYELOPROLIFERATIVE DISORDER BY REPRESSING THE NOTCH PATHWAY. 172
Assessment of BCR-ABL1 Transcript Levels By Digital PCR (dPCR) in CML Patients who Achieved a Deep Molecular Response (DMR: MR4.0, MR4.5 And MR5.0) with Tkis May Improve the Detection of Minimal Residual Disease (MRD) and the Selection of Patients for Treatment Free Remission (TFR) 170
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS 166
Identification of a Novel Mutation Predisposing to Familial AML and MDS Syndrome By a NGS Approach 159
Biological versus Clinical Risk Factors in Acute Myeloid Leukemia: Is There a Winner? 148
ANTI-CMV Immunoglobulins in Association with ANTI-CMV Drugs in Patients with Hematological Malignancies Submitted to Allogeneic STEM CELL Transplantation: A MULTI-Center Retrospective Experience 144
Digital PCR (Dpcr) a Step Forward to Detection and Quantification of Minimal Residual Disease (MRD) in Ph+/BCR-ABL1 Chronic Myeloid Leukemia (CML) 141
Comparative Study on Fresenius-ATG Versus Thymoglobuline-ATG for the Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Stem Cell Transplantation from Matched Unrelated Donor: A Single Center Experience on 76 Patients 138
ETV6: A Candidate Gene for Predisposition to “Blend Pedigrees”? A Case Report from the NEXT-Famly Clinical Trial 135
ANTI-CMV IMMUNOGLOBULINS IN ASSOCIATION WITH ANTI-CMV DRUGS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES SUBMITTED TO ALLOGENEIC STEM CELL TRANSPLANTATION: A MULTI-CENTRE RETROSPECTIVE EXPERIENCE 132
Allogeneic transplantation for patient with myelodisplastic sindromes: a single centre experience 132
IN VIVO STUDY (MYCEC0617) OF CD34+-HSC AND CEC MUTATIONAL PROFILE FOR INVESTIGATING CELL ORIGIN AND PATHOGENESIS OF PRIMARY MYELOFIBROSIS (PMF) 131
Case Report: Late Onset of Myelodysplastic Syndrome From Donor Progenitor Cells After Allogeneic Stem Cell Transplantation. Which Lessons Can We Draw From the Reported Case? 130
Safety and Efficacy of ATG-based GvHD prophylaxis in allogeneic stem cell transplantation for acute leukemia and myelodysplastic syndrome: a single center experience 128
DIGITAL PCR IN PH plus CHRONIC MYELOID LEUKEMIA PATIENTS FOR RECOGNITION OF "STABLE" DEEP MOLECULAR RESPONSE AND IDENTIFICATION OF BEST CANDIDATES TO TKI DISCONTINUATION 128
Liposomal doxorubicin for the treatment of iatrogenic kaposi sarcoma following hematopoietic stem cell transplantation 126
EXTRACORPOREAL PHOTOPHERESIS FOR THE TREATEMENT OF ACUTE AND CHRONIC GRAFT VERSUS HOST DISEASE: A RETROSPECTIVE MULTICENTRIC ANALYSIS ON 94 PATIENTS. 118
Neurological complications in adult allogeneic hematopoietic stem cell transplant patients: results from a retrospective multicentre study 112
Incidence and Outcome of Bacterial Blood Stream Infections in Allotransplanted Patients: Rethinking the Role of Fluoroquinolone Prophylaxis 105
Favourable/Intermediate ELN-Risk Acute Myeloid Leukemia to Transplant or Not to Transplant First-Line? 100
PF404 TUMOR-DERIVED EXOSOMES MAY BE USED AS NEW INFORMATIVE TOOL FOR THE DETECTION OF BONE MARROW RESIDUAL CML LEUKEMIC CELLS ACTIVITY 98
PS997 A NEW BIOMARKER OF RESPONSE TO 5-AZACITIDINE THERAPY IN MDS AND AML PATIENTS: SIRPB1 64
Letter in response to "Overcoming barriers to referral for CAR T-cell therapy in patients with non-Hodgkin aggressive B-cell lymphomas: a Delphi Consensus" 49
Totale 4.404
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.155
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.155
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022268 0 16 2 27 15 30 12 21 13 51 20 61
2022/2023297 42 13 14 22 24 66 0 33 50 9 14 10
2023/2024344 30 4 40 14 14 103 10 12 49 1 3 64
2024/2025685 12 13 0 102 61 56 27 35 132 43 111 93
2025/20261.445 128 125 94 202 180 118 240 55 84 137 55 27
2026/202727 13 14 0 0 0 0 0 0 0 0 0 0
Totale 4.404